Blog

How do Lean Six Sigma & EHR pipelines cut elderly dropout in oncology?

Operational convergence — Lean Six Sigma, EHR recruitment, risk-based monitoring and decentralized consent — is cutting elderly dropout in oncology. Data-driven pilots show 15–35% reductions; global regulatory alignment and advocacy partnerships will accelerate adoption.

Why join endocrine trials: GLP-1, diabetes flu and adrenal plans?

Explore why endocrine trials matter now: how GLP-1 advances, flu-season diabetes management, and adrenal emergency planning shape patient choices. Data-driven trends, outcome metrics, and practical steps for joining trials.

Hands-On Trial Guide: CGM, Pumps, Vaccines, GLP-1 Help

Analytical, forward-looking guide combining 2024-2025 trial data on CGM, pumps, vaccines, adrenal insufficiency, and GLP-1 access — with cost-effectiveness perspectives and guidance for parents of children with developmental disorders.

Expert Brief: Flu-Season Recruitment, Trop-2 M&A & Biosimilar Cuts

A practical, implementation-focused brief: preserve enrollment during flu peaks, capitalize on Trop-2 investor momentum and adapt protocols to biosimilar pricing pressure in breast cancer with concrete steps for sites and sponsors.

2026 Preview: Pediatric Endocrine & Diabetes Device Trial Prep

A practical, step-by-step 2026 preview for pediatric endocrine and diabetes device trial prep—actionable steps, a readiness checklist, cost-effectiveness framing, and how CRCs can streamline enrollment and data quality.

Future Trial Shifts: Flu, Breast Cancer, Diabetes DTx & Stroke

A practical guide to adapt trial recruitment and participation across flu season, breast cancer awareness, Type 2 Diabetes DTx, and stroke hotspots—actionable steps, patient prep, and participant rights tied to FDA/EMA guidance.